Elucidating Metabolic Maturation in the Healthy Fetal Brain Using ¹H-MR Spectroscopy

References

1. 1.↵
   2. Fayed N,
   3. Morales H,
   4. Modrego PJ, et al

   . White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination? Acad Radiol 2006;13:229–35 doi:10.1016/j.acra.2005.10.016 pmid:16428059

   CrossRefPubMed
2. 2.↵
   2. Broom KA,
   3. Anthony DC,
   4. Lowe JP, et al

   . MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis 2007;26:707–17 doi:10.1016/j.nbd.2007.04.001 pmid:17490889

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Barker PB

   . N-acetyl aspartate–a neuronal marker? Ann Neurol 2001;49:423–24 doi:10.1002/ana.90.abs pmid:11310618

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Moffett JR,
   3. Ross B,
   4. Arun P, et al

   . N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89–131 doi:10.1016/j.pneurobio.2006.12.003 pmid:17275978

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Urenjak J,
   3. Williams SR,
   4. Gadian DG, et al

   . Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992;59:55–61 doi:10.1111/j.1471-4159.1992.tb08875.x pmid:1613513

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Sartorius A,
   3. Lugenbiel P,
   4. Mahlstedt MM, et al

   . Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. J Neurosci Methods 2008;172:215–19 doi:10.1016/j.jneumeth.2008.04.028 pmid:18555535

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Gill SS,
   3. Small RK,
   4. Thomas DG, et al

   . Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2:196–200 doi:10.1002/nbm.1940020505 pmid:2561957

   CrossRefPubMed
8. 8.↵
   2. Katz-Brull R,
   3. Koudinov AR,
   4. Degani H

   . Choline in the aging brain. Brain Res 2002;951:158–65 doi:10.1016/S0006-8993(02)03155-4 pmid:12270493

   CrossRefPubMed
9. 9.↵
   2. José da Rocha A,
   3. Túlio Braga F,
   4. Carlos Martins Maia A Jr., et al

   . Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J Neuroimaging 2008;18:1–8 doi:10.1111/j.1552-6569.2007.00205.x pmid:18190488

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Wolfberg AJ,
    3. Robinson JN,
    4. Mulkern R, et al

    . Identification of fetal cerebral lactate using magnetic resonance spectroscopy. Am J Obstet Gynecol 2007;196:e9–e11 doi:10.1016/j.ajog.2006.09.036 pmid:17240215

    CrossRefPubMed
11. 11.↵
    2. Charles-Edwards GD,
    3. Jan W,
    4. To M, et al

    . Non-invasive detection and quantification of human foetal brain lactate in utero by magnetic resonance spectroscopy. Prenat Diagn 2010;30:260–66 doi:10.1002/pd.2463 pmid:20120007

    CrossRefPubMed
12. 12.↵
    2. Heerschap A,
    3. van den Berg PP

    . Proton magnetic resonance spectroscopy of human fetal brain. Am J Obstet Gynecol 1994;170:1150–51 doi:10.1016/S0002-9378(94)70111-3 pmid:8166200

    CrossRefPubMed
13. 13.↵
    2. Brighina E,
    3. Bresolin N,
    4. Pardi G, et al

    . Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy. Pediatr Neurol 2009;40:327–42 doi:10.1016/j.pediatrneurol.2008.11.001 pmid:19380068

    CrossRefPubMed
14. 14.↵
    2. Pugash D,
    3. Krssak M,
    4. Kulemann V, et al

    . Magnetic resonance spectroscopy of the fetal brain. Prenat Diagn 2009;29:434–41 doi:10.1002/pd.2248 pmid:19301351

    CrossRefPubMed
15. 15.↵
    2. Story L,
    3. Damodaram MS,
    4. Allsop JM, et al

    . Proton magnetic resonance spectroscopy in the fetus. Eur J Obstet Gynecol Reprod Biol 2011;158:3–8 doi:10.1016/j.ejogrb.2010.03.003 pmid:20413207

    CrossRefPubMed
16. 16.↵
    2. Limperopoulos C,
    3. Tworetzky W,
    4. McElhinney DB, et al

    . Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 2010;121:26–33 doi:10.1161/CIRCULATIONAHA.109.865568 pmid:20026783

    Abstract/FREE Full Text
17. 17.↵
    2. Clouchoux C,
    3. Guizard N,
    4. Evans AC, et al

    . Normative fetal brain growth by quantitative in vivo magnetic resonance imaging. Am J Obstet Gynecol 2012;206:173.e1–8 doi:10.1016/j.ajog.2011.10.002 pmid:22055336

    CrossRefPubMed
18. 18.↵
    2. Evangelou IE,
    3. Noeske R,
    4. Limperopoulos C

    . Retrospective correction of motion induced artifacts in 1H magnetic resonance spectroscopy of the fetal brain. In: Proceedings of the IEEE 12th International Symposium on Biomedical Imaging, Brooklyn, New York. April 16–19, 2015:853–57
19. 19.↵
    2. Provencher SW

    . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79 doi:10.1002/mrm.1910300604 pmid:8139448

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Longo R,
    3. Bampo A,
    4. Vidimari R, et al

    . Absolute quantitation of brain 1H nuclear magnetic resonance spectra. Comparison of different approaches. Invest Radiol 1995;30:119–203 doi:10.1097/00004424-199504000-00001 pmid:7635668

    CrossRefPubMed
21. 21.↵
    2. Kreis R,
    3. Ernst T,
    4. Ross BD

    . Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424–37 doi:10.1002/mrm.1910300405 pmid:8255190

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Diem K,
    3. Lentner C

    . Scientific Tables. Basle: J.R. Geigy; 1970
23. 23.↵
    2. Ganguly A

    . Fundamentals of Physical Chemistry. New Delhi: Pearson Education India; 2012
24. 24.↵
    2. Kreis R,
    3. Hofmann L,
    4. Kuhlmann B, et al

    . Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48:949–58 doi:10.1002/mrm.10304 pmid:12465103

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Tomiyasu M,
    3. Aida N,
    4. Endo M, et al

    . Neonatal brain metabolite concentrations: an in vivo magnetic resonance spectroscopy study with a clinical MR system at 3 Tesla. PloS One 2013;8:e82746 doi:10.1371/journal.pone.0082746 pmid:24312433

    CrossRefPubMed
26. 26.↵
    2. Cavassila S,
    3. Deval S,
    4. Huegen C, et al

    . Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed 2001;14:278–83 doi:10.1002/nbm.701 pmid:11410946

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Provencher SW

    . Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260–64 doi:10.1002/nbm.698 pmid:11410943

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Girard N,
    3. Gouny SC,
    4. Viola A, et al

    . Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy. Magn Reson Med 2006;56:768–75 doi:10.1002/mrm.21017 pmid:16964617

    CrossRefPubMed
29. 29.↵
    2. Kok RD,
    3. van den Berg PP,
    4. van den Bergh AJ, et al

    . Maturation of the human fetal brain as observed by 1H MR spectroscopy. Magn Reson Med 2002;48:611–16 doi:10.1002/mrm.10264 pmid:12353277

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Story L,
    3. Damodaram MS,
    4. Allsop JM, et al

    . Brain metabolism in fetal intrauterine growth restriction: a proton magnetic resonance spectroscopy study. Am J Obstet Gynecol 2011;205:483.e1–8 doi:10.1016/j.ajog.2011.06.032 pmid:21861969

    CrossRefPubMed
31. 31.↵
    2. Stanish WM,
    3. Taylor N

    . Estimation of the intraclass correlation coefficient for the analysis of covariance model. Am Stat 1983;37:221–24 doi:10.1080/00031305.1983.10483107

    CrossRefWeb of Science
32. 32.↵
    2. Kirkwood TB

    . Geometric means and measures of dispersion. Biometrics 1979;35:908–09
33. 33.↵
    2. Marshall I,
    3. Wardlaw J,
    4. Cannon J, et al

    . Reproducibility of metabolite peak areas in 1H MRS of brain. Magn Reson Imaging 1996;14:281–92 doi:10.1016/0730-725X(95)02084-7 pmid:8725194

    CrossRefPubMedWeb of Science
34. 34.↵
    2. van Werven JR,
    3. Hoogduin JM,
    4. Nederveen AJ, et al

    . Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. J Magn Reson Imaging 2009;30:444–48 doi:10.1002/jmri.21837 pmid:19629974

    CrossRefPubMed
35. 35.↵
    2. Gasparovic C,
    3. Bedrick EJ,
    4. Mayer AR, et al

    . Test-retest reliability and reproducibility of short-echo-time spectroscopic imaging of human brain at 3T. Magn Reson Med 2011;66:324–32 doi:10.1002/mrm.22858 pmid:21360748

    CrossRefPubMed
36. 36.↵
    2. Li BS,
    3. Wang H,
    4. Gonen O

    . Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 2003;21:923–28 doi:10.1016/S0730-725X(03)00181-4 pmid:14599543

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Wijtenburg SA,
    3. Rowland LM,
    4. Edden RA, et al

    . Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques. J Magn Reson Imaging 2013;38:460–67 doi:10.1002/jmri.23997 pmid:23292856

    CrossRefPubMed
38. 38.↵
    2. Fenton BW,
    3. Lin CS,
    4. Macedonia C, et al

    . The fetus at term: in utero volume-selected proton MR spectroscopy with a breath-hold technique—a feasibility study. Radiology 2001;219:563–66 doi:10.1148/radiology.219.2.r01ma29563 pmid:11323489

    CrossRefPubMed
39. 39.↵
    2. Kok RD,
    3. van den Bergh AJ,
    4. Heerschap A, et al

    . Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy. Am J Obstet Gynecol 2001;185:1011–15 doi:10.1067/mob.2001.117677 pmid:11717623

    CrossRefPubMed
40. 40.↵
    2. Berger-Kulemann V,
    3. Brugger PC,
    4. Pugash D, et al

    . MR spectroscopy of the fetal brain: is it possible without sedation? AJNR Am J Neuroradiol 2013;34:424–31 doi:10.3174/ajnr.A3196 pmid:22821916

    Abstract/FREE Full Text
41. 41.↵
    2. Brunel H,
    3. Girard N,
    4. Confort-Gouny S, et al

    . Fetal brain injury. J Neuroradiol 2004;31:123–37 doi:10.1016/S0150-9861(04)96979-9 pmid:15094650

    CrossRefPubMed
42. 42.↵
    2. Smith ME

    . A regional survey of myelin development: some compositional and metabolic aspects. J Lipid Res 1973;14:541–51pmid:4354155

    Abstract
43. 43.↵
    2. Podbielska M,
    3. Banik NL,
    4. Kurowska E, et al

    . Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci 2013;3:1282–324 doi:10.3390/brainsci3031282 pmid:24961530

    CrossRefPubMed
44. 44.↵
    2. Miller BL,
    3. Chang L,
    4. Booth R, et al

    . In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929–35 doi:10.1016/0024-3205(96)00182-8 pmid:8637421

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Hüppi PS,
    3. Posse S,
    4. Lazeyras F, et al

    . Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain. Pediatr Res 1991;30:574–78 doi:10.1203/00006450-199112000-00017 pmid:1666670

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Danielsen ER,
    3. Ross B

    . Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: M. Dekker; 1999
47. 47.↵
    2. Pouwels PJ,
    3. Brockmann K,
    4. Kruse B, et al

    . Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999;46:474–85 doi:10.1203/00006450-199910000-00019 pmid:10509371

    CrossRefPubMedWeb of Science
48. 48.↵
    2. Holland BA,
    3. Haas DK,
    4. Norman D, et al

    . MRI of normal brain maturation. AJNR Am J Neuroradiol 1986;7:201–08 pmid:3082150

    Abstract/FREE Full Text
49. 49.↵
    2. Nagae-Poetscher LM,
    3. McMahon M,
    4. Braverman N, et al

    . Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 2004;20:496–500 doi:10.1002/jmri.20128 pmid:15332258

    CrossRefPubMed